• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/16/21 10:29:00 AM ET
    $LSAQ
    Business Services
    Finance
    Get the next $LSAQ alert in real time by email
    SC 13G 1 formsc13g.htm

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934 (Amendment No._N/A_)*

     

    Lifesci Acquisition II Corp.

     

    (Name of Issuer)

     

    Common Stock

     

    (Title of Class of Securities)

     

    53229E103

     

    (CUSIP Number)

     

    December 31, 2020

     

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [X] Rule 13d-1(b)

     

    [_] Rule 13d-1(c)

     

    [_] Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No.   53229E103  

     

    1. NAME OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    RTW Investments, LP
       
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) [_]
    (b) [X]

    3. SEC USE ONLY
     
       
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware, United States of America
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
       
    5.

    SOLE VOTING POWER

     

    0

       
    6.

    SHARED VOTING POWER

     

    650,000*

       
    7.

    SOLE DISPOSITIVE POWER

     

    0

       
    8.

    SHARED DISPOSITIVE POWER

     

    650,000*

       
    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    650,000*

       
    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    [_]

       
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.58%*

       
    12.

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    PN, OO, IA

     

     

     

     

    CUSIP No.   53229E103  

     

    1. NAME OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    Roderick Wong
       
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) [_]
    (b) [X]

    3. SEC USE ONLY
     
       
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States of America
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
       
    5.

    SOLE VOTING POWER

     

    0

       
    6.

    SHARED VOTING POWER

     

    650,000*

       
    7.

    SOLE DISPOSITIVE POWER

     

    0

       
    8.

    SHARED DISPOSITIVE POWER

     

    650,000*

       
    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    650,000*

       
    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    [_]

       
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.58%

       
    12.

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    IN, HC

     

     

     

     

    Item 1. (a). Name of Issuer:
         
        Lifesci Acquisition II Corp.
         
         
      (b). Address of issuer’s principal executive offices:
         
       

    250 W. 55th St, # 3401

       

    New York, NY 10019

         
         
    Item 2. (a). Name of person filing:
         
        RTW Investments, LP
        Roderick Wong
         
         
      (b). Address or principal business office or, if none, residence:
         
        RTW Investments, LP
        40 10th Avenue
        Floor 7
        New York, New York 10014
         
         
        Roderick Wong
        c/o RTW Investments, LP
        40 10th Avenue
        Floor 7
        New York, New York 10014
         
      (c). Citizenship:
         
        RTW Investments, LP – Delaware
        Roderick Wong – United States of America
         
         
      (d). Title of class of securities:
         
        Common Stock

         
         
      (e). CUSIP No.:
         
        53229E103
         

     

     

     

     

    Item 3. If This Statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
       
      RTW Investments, LP:

     

      (a) [  ]   Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
      (b) [  ]   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
      (c) [  ]   Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
      (d) [  ]   Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
      (e) [X]   Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
      (f) [  ]   Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
      (g) [  ]   Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
      (h) [  ]   Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
      (i) [  ]   Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
      (j) [  ]   A non-U.S. institution in accordance with §240.13d-1(b)(ii)(J)
      (k) [  ]   Group, in accordance with §240.13d-1(b)(ii)(K) (a) [_]

     

      Roderick Wong:

     

      (a) [  ]   Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
      (b) [  ]   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
      (c) [  ]   Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
      (d) [  ]   Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
      (e) [  ]   Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
      (f) [  ]   Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
      (g) [X]   Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
      (h) [  ]   Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
      (i) [  ]   Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
      (j) [  ]   A non-U.S. institution in accordance with §240.13d-1(b)(ii)(J)
      (k) [  ]   Group, in accordance with §240.13d-1(b)(ii)(K) (a) [_]

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a) Amount beneficially owned:

     

        RTW Investments, LP – 650,000*
        Roderick Wong – 650,000*
         

     

      (b) Percent of class:

     

        RTW Investments, LP – 6.58%*
        Roderick Wong – 6.58%*
         

     

      (c) Number of shares as to which the person has:

     

      (i) Sole power to vote or to direct the vote
         
        RTW Investments, LP – 0
        Roderick Wong – 0
         
      (ii) Shared power to vote or to direct the vote
         
        RTW Investments, LP – 650,000*
        Roderick Wong – 650,000*
         
      (iii) Sole power to dispose or to direct the disposition of
         
        RTW Investments, LP – 0
        Roderick Wong – 0
         
      (iv) Shared power to dispose or to direct the disposition of
         
        RTW Investments, LP – 650,000*
        Roderick Wong – 650,000*

     

     

    * The shares of common stock (the "Shares"), of Lifesci Acquisition II Corp. (the "Company"), reported herein are held by one or more private funds (together the "Funds"), which are managed by RTW Investments, LP (the "Adviser"). The Adviser, in its capacity as the investment manager of Funds, has the power to vote and the power to direct the disposition of all Shares held by the Funds. Accordingly, for the purposes of Reg. Section 240.13d-3, the Adviser may be deemed to beneficially own an aggregate of 650,000 Shares, or 6.58% of the 9,884,041 Shares issued and outstanding as of December 31, 2020. Roderick Wong is the Managing Partner of the Adviser. This report shall not be deemed an admission that the Adviser, the Funds or any other person is the beneficial owner of the securities reported herein for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the reporting persons herein disclaims beneficial ownership of the Shares reported herein except to the extent of the reporting person’s pecuniary interest therein.

      

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].

     

    N/A

     

     

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

     

    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

     

    N/A

     

     

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

     

    N/A

     

     

     

    Item 8. Identification and Classification of Members of the Group.

     

    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d- 1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.

     

    N/A

     

     

     

    Item 9. Notice of Dissolution of Group.

     

    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.

     

    N/A

     

     

     

    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 16, 2021 RTW Investments, LP
         
      By: /s/ Roderick Wong
        Roderick Wong, Managing Partner
     
      Roderick Wong
       
      By: /s/ Roderick Wong
        Roderick Wong, Individually

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

     

    Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

     

     

     

    Get the next $LSAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LSAQ

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LSAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider De Silva Bhooshitha B.

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:48:37 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 3: New insider Pharmaceutical Product Development, Llc claimed ownership of 17,314,315 shares

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:46:17 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 3: New insider Lux Capital Management, Llc claimed ownership of 15,164,556 shares

    3 - Science 37 Holdings, Inc. (0001819113) (Issuer)

    10/18/21 4:32:23 PM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    SEC Filings

    View All

    LifeSci Acquisition II Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - Science 37 Holdings, Inc. (0001819113) (Filer)

    10/13/21 5:26:13 PM ET
    $LSAQ
    Business Services
    Finance

    LifeSci Acquisition II Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure

    8-K - Lifesci Acquisition II Corp. (0001819113) (Filer)

    10/6/21 4:47:03 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form 424B3 filed by LifeSci Acquisition II Corp.

    424B3 - Lifesci Acquisition II Corp. (0001819113) (Filer)

    9/24/21 7:01:10 AM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:30:20 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:16:02 PM ET
    $LSAQ
    Business Services
    Finance

    SEC Form SC 13D filed by LifeSci Acquisition II Corp.

    SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)

    10/18/21 4:05:14 PM ET
    $LSAQ
    Business Services
    Finance

    $LSAQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE

    Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol "SNCE"Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued growthScience 37 to fuel its mission to enable universal access to clinical research which has proven to accelerate patient enrollment, minimize patient burden, and include underserved patient populations Investments targeted to enhance the Science 37 Operating System to decentralize clinical trial execution and enable more agile clinical trials LOS ANGELES and NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc., the Operating System for today's agile clinical trials, announced today

    10/7/21 8:00:00 AM ET
    $LSAQ
    Business Services
    Finance

    LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination

    NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ:LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Science 37, Inc. About LifeSci Acquisition II Corp. LifeSci Acquisition II Corp. (NASDAQ:LSAQ) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganizat

    6/16/21 9:00:00 AM ET
    $LSAQ
    Business Services
    Finance

    Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

    Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research $80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no public warrants $200 million via fully committed and upsized PIPE from leading institutional and strategic investors including Redmile Group; funds and accounts managed by BlackRock; Casdin Capital; dRx Capital (Novartis Pharma AG); LifeSci Venture Partners; Lux Capital; Mubadala Capital, the asset manageme

    5/7/21 7:55:00 AM ET
    $LSAQ
    Business Services
    Finance